Filing Details

Accession Number:
0000950170-24-060586
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-15 17:09:42
Reporting Period:
2024-05-13
Accepted Time:
2024-05-15 17:09:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1876279 Andrea Sabens C/O Lantheus Holdings, Inc.
201 Burlington Road, South Bldg
Bedford MA 01730
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-13 341 $76.89 62,898 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.